Crash Course in Cures: AYA AML Venetoclax & Azacitidine
New treatments come out every day, making it hard to know which ones may work best for you. Join HealthTree as we learn from Dr. Justin Taylor about how to best use Venetoclax & Azacitidine together in treatment as an AYA AML Patient. There will be a Q&A session at the end so come with questions!
Eliza introduces the agenda for the event and Dr. Justin Taylor.
Join HealthTree as we learn from Dr. Justin Taylor about how to best use Venetoclax & Azacitidine together in treatment as an AYA AML Patient.
Come with your questions and we will answer them!
Eliza Prickett
Eliza joined HealthTree in March 2026 as the Leukemia Patient Health Education Manager. Prior to joining HealthTree, she completed a Master’s Degree in Public Health from Brigham Young University and worked with a variety of underserved populations in government and healthcare settings, including Americorps and Utah Health Department. When not in office, Eliza enjoys reading, writing and learning new things about the world.
Justin Taylor
Justin Taylor, MD, is a physician-scientist devoted to improving outcomes for patients with hematologic malignancies. The Taylor lab studies the role of recurrent mutations in hematologic malignancies and how to target them with novel therapeutics using animal modeling, molecular biology, and single-cell genomic techniques. Dr. Taylor holds a faculty position in the Department of Medicine, Division of Hematology where he sees patients with hematologic malignancies. He is the principal investigator on grants sponsored by the National Cancer Institute (K08), American Society of Hematology, the Robert Wood Johnson Foundation and the Edward P. Evans Foundation for MDS. He has received Young Investigator Awards from ASCO Conquer Cancer Foundation, Hairy Cell Leukemia Foundation, and Evans MDS Foundation.